Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: A report from the Haematological malignancy Research Network

BMC Hematology

Volumn 13, Issue 1, 2013, Pages 9-

  Howell, Debra A ^a   Smith, Alexandra G ^a   Jack, Andrew ^b   Patmore, Russell ^c   Macleod, Una ^d   Mironska, Emma ^b   Roman, Eve ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c CASTLE HILL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF HULL   (United Kingdom)

Author keywords

Diagnostic delay; Haematological malignancies; Help seeking

Indexed keywords

ACUTE MYELOID LEUKEMIA; ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; BLEEDING; CANCER RESEARCH; CONSULTATION; DELAYED DIAGNOSIS; DIFFUSE LARGE B CELL LYMPHOMA; FATIGUE; FEMALE; HUMAN; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MYELOMA; ONSET AGE; PAIN; PRACTICE GUIDELINE; SELF REPORT; SKIN BRUISING; SYMPTOMATOLOGY;

EID: 84889639746     PISSN: None     EISSN: 20521839     Source Type: Journal    
DOI: 10.1186/2052-1839-13-9     Document Type: Article

References (41)

1. Summerfield GP, Carey PJ, Galloway MJ, Tinegates HN: An audit of delays in diagnosis and treatment of lymphoma in district hospitals in the northern region of the United Kingdom. Clin Lab Haematol 2000, 22:157–160.
2. NICE: Improving outcomes in haematological cancers: research evidence. London: Department of Health; 2003.
3. NICE: Improving outcomes in haematological cancers: the manual. London: Department of Health; 2003.
4. Allgar VL, Neal RD: Delays in the diagnosis of six cancers: analysis of data from the national survey of NHS patients: cancer. Br J Cancer 2005, 92:1959–1970.
5. Howell DA, Smith AG, Roman E: Lymphoma: variations in time to diagnosis and treatment. Eur J Cancer Care (Engl) 2006, 15:272–278.
6. Howell DA, Smith AG, Roman E: Referral pathways and diagnosis: UK government actions fail to recognize complexity of lymphoma. Eur J Cancer Care (Engl) 2007, 16:529–532.
7. Howell DA, Smith AG, Roman E: Help-seeking behaviour in patients with lymphoma. Eur J Cancer Care (Engl) 2008, 17:394–403.
8. Kariyawasan CC, Hughes DA, Jayatillake MM, Mehta AB: Multiple myeloma: causes and consequences of delay in diagnosis. QJM 2007, 100:635–640.
9. Friese CR, Abel GA, Magazu LS, Neville BA, Richardson LC, Earle CC: Diagnostic delay and complications for older adults with multiple myeloma. Leuk Lymphoma 2009, 50:392–400.
10. Friese CR, Earle CC, Magazu LS, Brown JR, Neville BA, Hevelone ND, Richardson LC, Abel GA: Timeliness and quality of diagnostic care for medicare recipients with chronic lymphocytic leukemia. Cancer 2011, 117:1470–1477.
11. Irfan SM, Bhurgri Y: Clinico-pathological features and outcomes in chronic phase chronic myeloid leukemia patients treated with hydroxyurea. Asian Pac J Cancer Prev 2009, 10:591–594.
12. Ong F, Hermans J, Noordijk EM, Wijermans PW, Kluin-Nelemans JC: Presenting signs and symptoms in multiple myeloma: high percentages of stage III among patients without apparent myeloma-associated symptoms. Ann Hematol 1995, 70:149–152.
13. Department of Health: National survey report: national cancer patient experience survey programme. London: Department of Health; 2010.
14. Department of Health: National audit of cancer diagnosis in primary care. London: Department of Health; 2011.
15. Lyratzopoulos G, Abel GA, McPhail S, Neal RD, Rubin GP: Measures of promptness of cancer diagnosis in primary care: secondary analysis of national audit data on patients with 18 common and rarer cancers. Br J Cancer 2013, 108:686–690.
16. Elliss-Brookes L, McPhail S, Ives A, Greenslade M, Shelton J, Hiom S, Richards M: Routes to diagnosis for cancer – determining the patient journey using multiple routine data sets. Br J Cancer 2012, 107:1220–1226.
17. Lyratzopoulos G, Neal RD, Barbiere JM, Rubin GP, Abel GA: Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 national cancer patient experience survey in England. Lancet Oncol 2012, 13:353–365.
18. Thomson CS, Forman D: Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results? Br J Cancer 2009, 101(Suppl 2):S102–S109.
19. Abdel-Rahman M, Stockton D, Rachet B, Hakulinen T, Coleman MP: What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? Br J Cancer 2009, 101(Suppl 2):S115–S124.
20. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW: WHO classification of tumours of haematopoietic and lymphoid tissues, Fourth Edition. France: International Agency for Research on Cancer; 2008.
21. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71–96.
22. Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893–2917.
23. Department of Health: The NHS cancer plan: a plan for investment, a plan for reform. London: Department of Health; 2000.
24. Department of Health: Cancer reform strategy. London: Department of Health; 2007.
25. Department of Health: Improving outcomes: a strategy for cancer. London: Department of Health; 2011.
26. Richards MA: The size of the prize for earlier diagnosis of cancer in England. Br J Cancer 2009, 101(Suppl 2):S125–S129.
27. Richards MA: The National Awareness and Early Diagnosis Initiative in England: assembling the evidence. Br J Cancer 2009, 101(Suppl 2):S1–S4.
28. NICE: Referral guidelines for suspected cancer. London: Department of Health; 2005.
29. Riccardi A, Gobbi PG, Ucci G, Bertoloni D, Luoni R, Rutigliano L, Ascari E: Changing clinical presentation of multiple myeloma. Eur J Cancer 1991, 27:1401–1405.
30. Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar SV, Offord JR, Larson DR, Plevak ME, Therneau TM, Greipp PR: Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003, 78:21–33.
31. Mai Y, Qi P, Xu Y, Zou D, Wang Y, Zhao Y, Yang R, Xiao Z, Qiu L: Clinical and laboratory features of newly diagnosed multiple myeloma: a retrospective, single-centre analysis. Chin Med J 2007, 120:1727–1729.
32. Molassiotis A, Wilson B, Brunton L, Chandler C: Mapping patients' experiences from initial change in health to cancer diagnosis: a qualitative exploration of patient and system factors mediating this process. Eur J Cancer Care 2010, 19:98–109.
33. Savage DG, Szydlo RM, Goldman JM: Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period. Br J Haematol 1997, 96:111–116.
34. Talamo G, Farooq U, Zangari M, Liao J, Dolloff NG, Loughran TP Jr, Epner E: Beyond the CRAB symptoms: a study of presenting clinical manifestations of multiple myeloma. Clin Lymphoma Myeloma Leuk 2010, 10:464–468.
35. Johansson E, Wilson B, Brunton L, Tishelman C, Molassiotis A: Symptoms before, during, and 14 months after the beginning of treatment as perceived by patients with lymphoma. Oncol Nurs Forum 2010, 37:E105–E113.
36. Smith A, Roman E, Howell D, Jones R, Patmore R, Jack A: The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research. Br J Haematol 2010, 148:739–753.
37. Smith A, Howell D, Patmore R, Jack A, Roman E: Incidence of haematological malignancy by sub-type: a report from the haematological malignancy research network. Br J Cancer 2011, 105:1684–1692.
38. Walter F, Webster A, Scott S, Emery J: The Andersen model of total patient delay: a systematic review of its application in cancer diagnosis. J Health Serv Res Policy 2012, 17:110–118.
39. Stata-Corp: Stata data analysis and statistical software. TX, USA: Stata-Corp, College Station; 2012.
40. Norum J: The effect of diagnostic delay in patients with Hodgkin's lymphoma. Anticancer Res 1995, 15:2707–2710.
41. Hansen RP, Vedsted P, Sokolowski I, Søndergaard J, Olesen F: Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res 2011, 11:284.